23 December 2008
Cytokinetics retains development and commercialization rights to ispinesib and SB-743921
23 December 2008
GlaxoSmithKline and Archemix form strategic alliance to develop aptamers to treat inflammatory diseases
22 December 2008
GlaxoSmithKline to cease providing corporate political contributions
22 December 2008
GSK and Theravance announce positive phase 2b results for LABA `444 in the treatment of COPD in the Horizon Development Programme
22 December 2008
GSK to acquire BMS Pakistan
19 December 2008
GSK files for European Marketing Authorisation of Duodart® for benign prostatic hyperplasia
18 December 2008
GSK initiates phase lll programme for novel cardiovascular medication, darapladib
17 December 2008
GlaxoSmithKline and Dynavax announce worldwide strategic alliance
12 December 2008
'Green' canal water helps fuel 21st century business
11 December 2008
GlaxoSmithKline statement on FDA Advisory Committee vote on use of asthma medicines containing long-acting beta-agonists
Back to top

